The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

The essential thrombocythemia market is on a growth trajectory, driven by increasing diagnosis rates, aging population ...

Take care of the person and not the disease. It is often said. And it is important that the approach is not limited to ...